Skip to main content

fda_approval · bla · info

EISAI INC — BLA approval: LEQEMBI IQLIK (unspecified)

Event date
2026-07-13 00:00:00Z
Observed
2026-07-16 04:30:51Z
Source ID
BLA761375-1
Payload hash
27383ea06b58693825a5af70

Summary

EISAI INC received a priority supplemental BLA approval for LEQEMBI IQLIK (unspecified) on 2026-07-13. Dosage form: INJECTABLE. Application #: BLA761375.

Entities

Frequently asked questions

Has EISAI INC had other FDA enforcement actions?
This is the only FDA action Argus HQ has on file for EISAI INC as of 2026-07-16. Argus ingests new FDA enforcement records daily.
What kind of FDA record is this?
This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-07-13; Argus observed and indexed it on 2026-07-16.
Where can I verify this record directly with FDA?
The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA
Argus HQ Research (2026). EISAI INC — BLA approval: LEQEMBI IQLIK (unspecified). Digital Empire LLC. Retrieved from https://argushq.ai/events/fda-approval-eisai-inc-bla761375-1
MLA
"EISAI INC — BLA approval: LEQEMBI IQLIK (unspecified)." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/events/fda-approval-eisai-inc-bla761375-1.
Chicago
Argus HQ Research. "EISAI INC — BLA approval: LEQEMBI IQLIK (unspecified)." Digital Empire LLC. Accessed July 16, 2026. https://argushq.ai/events/fda-approval-eisai-inc-bla761375-1.
BibTeX
@misc{argushq_argushq_ai_events_fda_approval_eisai_inc_bla761375_1_2026,
  title = {EISAI INC — BLA approval: LEQEMBI IQLIK (unspecified)},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/events/fda-approval-eisai-inc-bla761375-1},
  note = {Accessed: July 16, 2026}
}

Informational only. Not legal, financial, or medical advice.